Membranous Glomerulopathy in a Patient on Captopril

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1978 • 364 citations

IMMUNE-COMPLEX GLOMERULOPATHY IN PATIENTS TREATED WITH CAPTOPRIL

1980 • 305 citations

LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSION

1979 • 191 citations

Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.

1979 • 185 citations

Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.

1979 • 177 citations

A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow.

1977 • 164 citations

HEALTH VISITING AND GENERAL PRACTICE.

1964 • 120 citations

CAPTOPRIL-ASSOCIATED AGRANULOCYTOSIS

1980 • 101 citations

The Effect of the Converting Enzyme Inhibitor SQ 20.881 on Kinins, Renin‐Angiotensin‐Aldosterone and Catecholamines in Relation to Blood Pressure in Hypertensive Patients

1978 • 48 citations

Special problems in the radioimmunoassay of plasma aldosterone without prior extraction and purification

1978 • 38 citations

Mechanism of angiotensin I converting enzyme inhibition by SQ20,881 (less than Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) in vivo. Further evidence for extrapulmonary conversion.

1979 • 31 citations

Converting-enzyme inhibition experiences with captopril in hypertensive patients

1979 • 2 citations

Cited By (0)

Loading...